Pegylated liposomal doxorubicin HCL (PLD; Caelyx/Doxil): experience with long-term maintenance in responding patients with recurrent epithelial ovarian cancer. (Q40457754)
Jump to navigation
Jump to search
scientific article published on 13 February 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pegylated liposomal doxorubicin HCL (PLD; Caelyx/Doxil): experience with long-term maintenance in responding patients with recurrent epithelial ovarian cancer. |
scientific article published on 13 February 2007 |
Statements
1 reference
Pegylated liposomal doxorubicin HCL (PLD; Caelyx/Doxil): experience with long-term maintenance in responding patients with recurrent epithelial ovarian cancer. (English)
1 reference
1 reference
1 reference
E Andreopoulou
1 reference
D Gaiotti
1 reference
E Kim
1 reference
A Downey
1 reference
D Mirchandani
1 reference
A Hamilton
1 reference
Allan Jacobs
1 reference
13 February 2007
1 reference
1 reference
18
1 reference
4
1 reference
716-721
1 reference
Identifiers
1 reference
1 reference